Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Homology Medicines Inc. (NASDAQ:FIXX) compete on a level playing field in the Biotechnology ...
Feeds
13354 items (13354 unread) in 74 feeds
Acinar Cell Carcinoma
(66 unread)
Acinic Cell Carcinoma
(48 unread)
Adenoid Cystic Carcinoma
(261 unread)
Adrenal Gland Cancer
(1125 unread)
Ampulla Of Vater
(174 unread)
Anal Cancer
(1482 unread)
Angiosarcoma
(433 unread)
Appendix Cancer
(154 unread)
Bile Duct Cancer
(1492 unread)
Brain and CNS
(1891 unread)
Carcinoid
(634 unread)
Endocrine/Neuroendocrine
(1797 unread)
Gall Bladder Cancer
(634 unread)
Hemangioendothelioma
(82 unread)
Hepatoblastoma
(212 unread)
Pancreas
(156 unread)
Phyllodes
(83 unread)
PMP and Mucinous Tumors
(109 unread)
Rhabdomyosarcoma
(455 unread)
Sarcoma
(2066 unread)
Google - Angiosarcoma (100 unread)
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Homology Medicines Inc. (NASDAQ:FIXX) - Thе Mоnіtоr
Posted: March 26th, 2019, 11:45pm GMT
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Homology Medicines Inc. (NASDAQ:FIXX) Thе Mоnіtоr -
BidaskScore Ups TRACON Pharmaceuticals (TCON) To "Buy"; BERGENBIO AS ORDINARY SHARES NORWAY (BRRGF) Shorts Decreased By 20.51% - Lives Advice
Posted: March 25th, 2019, 8:40am GMT
BidaskScore Ups TRACON Pharmaceuticals (TCON) To "Buy"; BERGENBIO AS ORDINARY SHARES NORWAY (BRRGF) Shorts Decreased By 20.51% Lives AdviceTRACON Pharmaceuticals (NASDAQ:TCON) Upgrade In a a report made public on Sunday, 24 March, research analysts at BidaskScore's research division ...
-
Should Investors Turn Their Attention to TRACON Pharmaceuticals (NASDAQ:TCON)? BidaskScore Upgrades Shares | Thorold News - Thorold News
Posted: March 25th, 2019, 11:37pm GMT
Should Investors Turn Their Attention to TRACON Pharmaceuticals (NASDAQ:TCON)? BidaskScore Upgrades Shares | Thorold News Thorold NewsBidaskScore has increased shares of TRACON Pharmaceuticals (NASDAQ:TCON) to a solid Buy in analysts note issued to clients on today. The stock ...
-
Motley Fool Wealth Management Has Lifted Texas Roadhouse (TXRH) Stake; Athenex (ATNX) Shorts Lowered By 2.6% - EN Digest
Posted: March 24th, 2019, 4:25pm GMT
Motley Fool Wealth Management Has Lifted Texas Roadhouse (TXRH) Stake; Athenex (ATNX) Shorts Lowered By 2.6% EN DigestMotley Fool Wealth Management Llc increased Texas Roadhouse Inc (TXRH) stake by 2.85% reported in 2018Q4 SEC filing. Motley Fool Wealth Management ...
-
TRACON Pharmaceuticals Inc. (TCON) and China Biologic Products Holdings Inc. (NASDAQ:CBPO) Contrasting side by side - D Minute
Posted: March 24th, 2019, 10:46am GMT
TRACON Pharmaceuticals Inc. (TCON) and China Biologic Products Holdings Inc. (NASDAQ:CBPO) Contrasting side by side D MinuteBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and China Biologic Products Holdings Inc. (NASDAQ:CBPO) are each other's competitor in the ...
-
Athenex, Inc. (ATNX) Trades at $12.26 After Triangle; YARA INTERNATIONAL ASA ORDINARY SHARES (YRAIF) Shorts Lowered By 7.41% - Standard Recorder
Posted: March 24th, 2019, 10:38am GMT
Athenex, Inc. (ATNX) Trades at $12.26 After Triangle; YARA INTERNATIONAL ASA ORDINARY SHARES (YRAIF) Shorts Lowered By 7.41% Standard RecorderAthenex, Inc. (ATNX) formed triangle with $11.28 target or 8.00% below today's $12.26 share price. Athenex, Inc. (ATNX) has $821.71M valuation. The stock ...
-
Vaxart (VXRT) vs. TRACON Pharmaceuticals (NASDAQ:TCON) Head to Head Comparison - Fairfield Current
Posted: March 24th, 2019, 2:22am GMT
Vaxart (VXRT) vs. TRACON Pharmaceuticals (NASDAQ:TCON) Head to Head Comparison Fairfield CurrentVaxart (NASDAQ:VXRT) and TRACON Pharmaceuticals (NASDAQ:TCON) are both small-cap medical companies, but which is the superior business? We will ...
-
Anavex Life Sciences Corp. (AVXL) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side - Port Courier
Posted: March 24th, 2019, 11:30pm GMT
Anavex Life Sciences Corp. (AVXL) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side Port CourierWe are comparing Anavex Life Sciences Corp. (NASDAQ:AVXL) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) on their dividends, institutional ...
-
Reviewing Intec Pharma Ltd. (NTEC)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The Hi New Ulm
Posted: March 23rd, 2019, 10:48am GMT
Reviewing Intec Pharma Ltd. (NTEC)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results The Hi New UlmSince Intec Pharma Ltd. (NASDAQ:NTEC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are part of the Biotechnology industry, they are influenced by ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and OHR Pharmaceutical Inc. (NASDAQ:OHRP)'s results - The FinExaminer
Posted: March 23rd, 2019, 2:57am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and OHR Pharmaceutical Inc. (NASDAQ:OHRP)'s results The FinExaminerTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and OHR Pharmaceutical Inc. (NASDAQ:OHRP), are influenced by compare since they are both players in the.
-
Analysts Set Expectations for TRACON Pharmaceuticals Inc’s Q1 2019 Earnings (TCON) - Fairfield Current
Posted: March 23rd, 2019, 2:05am GMT
Analysts Set Expectations for TRACON Pharmaceuticals Inc’s Q1 2019 Earnings (TCON) Fairfield CurrentTRACON Pharmaceuticals Inc (NASDAQ:TCON) – Stock analysts at Jefferies Financial Group issued their Q1 2019 EPS estimates for shares of TRACON ...
-
Reviewing Neptune Wellness Solutions Inc. (NEPT)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The Hi New Ulm
Posted: March 22nd, 2019, 12:47pm GMT
Reviewing Neptune Wellness Solutions Inc. (NEPT)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results The Hi New UlmBoth Neptune Wellness Solutions Inc. (NASDAQ:NEPT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete on a level playing field in the ...
-
Athenex, Inc. (ATNX) Trades at $12.65 After Triangle; Marshall Wace Llp Increased Honeywell Intl (HON) Stake - The FinHeadLines
Posted: March 22nd, 2019, 10:30am GMT
Athenex, Inc. (ATNX) Trades at $12.65 After Triangle; Marshall Wace Llp Increased Honeywell Intl (HON) Stake The FinHeadLinesAthenex, Inc. (ATNX) formed triangle with $12.14 target or 4.00% below today's $12.65 share price. Athenex, Inc. (ATNX) has $847.85M valuation. The stock ...
-
As of Mar 22, 2019 Athenex Inc (NASDAQ:ATNX) Sellers Decreased Their Shorts By 2.6% - K Reviewer
Posted: March 22nd, 2019, 10:14am GMT
As of Mar 22, 2019 Athenex Inc (NASDAQ:ATNX) Sellers Decreased Their Shorts By 2.6% K ReviewerAthenex Inc (NASDAQ:ATNX) noted a decrease of 2.6% in shares shorted. It was published in March by FINRA the 5.60 million shares shorted on ATNX.
-
Contrasting of Akari Therapeutics Plc (AKTX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The FinExaminer
Posted: March 22nd, 2019, 7:59am GMT
Contrasting of Akari Therapeutics Plc (AKTX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The FinExaminerAkari Therapeutics Plc (NASDAQ:AKTX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), are influenced by contrast since they are both players in the.
-
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side - Lives Advice
Posted: March 22nd, 2019, 2:53am GMT
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side Lives AdviceBiohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete against each other in the ...
-
Comparison of Rubius Therapeutics Inc. (RUBY) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The FinHeadLines
Posted: March 21st, 2019, 9:49pm GMT
Comparison of Rubius Therapeutics Inc. (RUBY) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The FinHeadLinesRubius Therapeutics Inc. (NASDAQ:RUBY) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete with each other in the Biotechnology sector. We will ...
-
TRACON Pharmaceuticals Inc. (TCON) and Histogenics Corporation (NASDAQ:HSGX) Comparing side by side - Lives Advice
Posted: March 21st, 2019, 2:13pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Histogenics Corporation (NASDAQ:HSGX) Comparing side by side Lives AdviceWe will be contrasting the differences between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Histogenics Corporation (NASDAQ:HSGX) as far as ...
-
Comparison of Flex Pharma Inc. (FLKS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Moveefy
Posted: March 21st, 2019, 4:00am GMT
Comparison of Flex Pharma Inc. (FLKS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The MoveefyFlex Pharma Inc. (NASDAQ:FLKS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), both competing one another are Biotechnology companies. We will ...
-
Contrasting of Taiwan Liposome Company Ltd. (TLC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - Thе Mоnіtоr
Posted: March 21st, 2019, 2:11am GMT
Contrasting of Taiwan Liposome Company Ltd. (TLC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Thе MоnіtоrBoth Taiwan Liposome Company Ltd. (NASDAQ:TLC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are each other's competitor in the Biotechnology ...
-
Is Buying Athenex Inc (NASDAQ:ATNX), Having Lower Short Interest a Winning Strategy? | Thorold News - Thorold News
Posted: March 21st, 2019, 11:10pm GMT
Is Buying Athenex Inc (NASDAQ:ATNX), Having Lower Short Interest a Winning Strategy? | Thorold News Thorold NewsThe stock of Athenex Inc (NASDAQ:ATNX) registered a decrease of 2.6% in short interest. ATNX's total short interest was 5.60M shares in March as published ...
-
TRACON Pharmaceuticals Inc. (TCON) and Chimerix Inc. (NASDAQ:CMRX) Comparing side by side - Port Courier
Posted: March 20th, 2019, 9:01pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Chimerix Inc. (NASDAQ:CMRX) Comparing side by side Port CourierThis is therefore a contrasting of the risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation in TRACON.
-
People"s United Financial, Inc. (PBCT) Analysts See $0.33 EPS; Athenex (ATNX) Shorts Decreased By 2.6% - Standard Recorder
Posted: March 20th, 2019, 11:41am GMT
People"s United Financial, Inc. (PBCT) Analysts See $0.33 EPS; Athenex (ATNX) Shorts Decreased By 2.6% Standard RecorderAnalysts expect People's United Financial, Inc. (NASDAQ:PBCT) to report $0.33 EPS on April, 18.They anticipate $0.03 EPS change or 10.00% from last ...
-
A 52-Year-Old Woman With Splenomegaly - Cancer Network
Posted: March 20th, 2019, 11:41am GMT
A 52-Year-Old Woman With Splenomegaly Cancer NetworkA 52-year-old woman presents with abdominal discomfort, which on physical examination revealed the presence of splenomegaly. A splenectomy is performed.
-
Athenex, Inc. (ATNX) Trades at $12.05 After Triangle; Profile of 6 Analysts Covering Callon Petroleum Company (CPE) - The FinExaminer
Posted: March 20th, 2019, 10:32am GMT
Athenex, Inc. (ATNX) Trades at $12.05 After Triangle; Profile of 6 Analysts Covering Callon Petroleum Company (CPE) The FinExaminerAthenex, Inc. (ATNX) formed triangle with $11.09 target or 8.00% below today's $12.05 share price. Athenex, Inc. (ATNX) has $807.63M valuation. The stock ...
-
Athenex, Inc. (ATNX) Forms Ascending Triangle Pattern at $12.05 - K Reviewer
Posted: March 20th, 2019, 9:36am GMT
Athenex, Inc. (ATNX) Forms Ascending Triangle Pattern at $12.05 K ReviewerAthenex, Inc. (ATNX) made ascending triangle with $11.21 price target or 7.00 % below today's $12.05 share price. Athenex, Inc. (ATNX) has $807.63M market ...
-
TRACON Pharmaceuticals Inc. (TCON) and 22nd Century Group Inc. (NYSEAMERICAN:XXII) Contrasting side by side - The Yomi Blog
Posted: March 20th, 2019, 4:45am GMT
TRACON Pharmaceuticals Inc. (TCON) and 22nd Century Group Inc. (NYSEAMERICAN:XXII) Contrasting side by side The Yomi BlogBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and 22nd Century Group Inc. (NYSEAMERICAN:XXII) are Biotechnology companies, competing one ...
-
Angiosarcomas Treatment Market Progresses for Huge Profits by 2026 With Prominent Key Players Genentech, Inc., Pfizer Inc., Janssen Global Services, LLC, Bayer AG, Sanofi, and Amgen Inc. - openPR
Posted: March 20th, 2019, 4:08am GMT
Angiosarcomas Treatment Market Progresses for Huge Profits by 2026 With Prominent Key Players Genentech, Inc., Pfizer Inc., Janssen Global Services, LLC, Bayer AG, Sanofi, and Amgen Inc. openPRAngiosarcoma is a rare cancer of the inner lining of blood vessels, which occur in any area of the body, including the skin, breast, liver, spleen, and deep tissue ...
-
Needham & Company LLC Reiterates “Buy” Rating for TRACON Pharmaceuticals (NASDAQ:TCON) - XNewsPress
Posted: March 20th, 2019, 3:11am GMT
Needham & Company LLC Reiterates “Buy” Rating for TRACON Pharmaceuticals (NASDAQ:TCON) XNewsPressNeedham & Company LLC restated their buy rating on shares of TRACON Pharmaceuticals (NASDAQ:TCON) in a research note published on Friday, March 1st ...
-
TRACON Pharmaceuticals Inc. (TCON) and CEL-SCI Corporation (NYSEAMERICAN:CVM) Contrasting side by side - The Yomi Blog
Posted: March 19th, 2019, 5:31pm GMT
TRACON Pharmaceuticals Inc. (TCON) and CEL-SCI Corporation (NYSEAMERICAN:CVM) Contrasting side by side The Yomi BlogBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and CEL-SCI Corporation (NYSEAMERICAN:CVM) are Biotechnology companies, competing one ...
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Sophiris Bio Inc. (NASDAQ:SPHS) - The Moveefy
Posted: March 19th, 2019, 4:11pm GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Sophiris Bio Inc. (NASDAQ:SPHS) The MoveefyThis is a contrast between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Sophiris Bio Inc. (NASDAQ:SPHS) based on their profitability, institutional ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Akari Therapeutics Plc (NASDAQ:AKTX)'s results - The Moveefy
Posted: March 19th, 2019, 10:51am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Akari Therapeutics Plc (NASDAQ:AKTX)'s results The MoveefyTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Akari Therapeutics Plc (NASDAQ:AKTX), both competing one another are Biotechnology companies.
-
Financial Comparison: Cidara Therapeutics (CDTX) & TRACON Pharmaceuticals (NASDAQ:TCON) - Fairfield Current
Posted: March 19th, 2019, 10:38am GMT
Financial Comparison: Cidara Therapeutics (CDTX) & TRACON Pharmaceuticals (NASDAQ:TCON) Fairfield CurrentTRACON Pharmaceuticals (NASDAQ:TCON) and Cidara Therapeutics (NASDAQ:CDTX) are both small-cap medical companies, but which is the superior ...
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Trend Unknown, Especially After Increased Shorts - MoneyMakingArticles
Posted: March 19th, 2019, 9:42am GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Trend Unknown, Especially After Increased Shorts MoneyMakingArticlesThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered an increase of 73.68% in short interest. TCON's total short interest was 430200 shares in.
-
TRACON Pharmaceuticals (TCON) Stock Rating Reaffirmed by Needham & Company LLC - Fairfield Current
Posted: March 19th, 2019, 2:43am GMT
TRACON Pharmaceuticals (TCON) Stock Rating Reaffirmed by Needham & Company LLC Fairfield CurrentNeedham & Company LLC restated their buy rating on shares of TRACON Pharmaceuticals (NASDAQ:TCON) in a research note published on Friday, March 1st ...
-
Global Soft Tissue Sarcoma Treatment Market Opportunity Assessment to Reveal Lucrative Growth Prospects for Players - Digital Day News
Posted: March 18th, 2019, 4:48pm GMT
Global Soft Tissue Sarcoma Treatment Market Opportunity Assessment to Reveal Lucrative Growth Prospects for Players Digital Day NewsSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
Global Soft Tissue Sarcoma Treatment Market Opportunity Assessment to Reveal Lucrative Growth Prospects for Players - Digital Day News
Posted: March 18th, 2019, 4:48pm GMT
Global Soft Tissue Sarcoma Treatment Market Opportunity Assessment to Reveal Lucrative Growth Prospects for Players Digital Day NewsSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
Athenex, Inc. (ATNX) Trades at $11.78 After Triangle; Punch & Associates Investment Management Lifted By $1.02 Million Its Thestreet (TST) Stake - The FinReviewer
Posted: March 18th, 2019, 11:53am GMT
Athenex, Inc. (ATNX) Trades at $11.78 After Triangle; Punch & Associates Investment Management Lifted By $1.02 Million Its Thestreet (TST) Stake The FinReviewerPunch & Associates Investment Management Inc increased Thestreet Inc (TST) stake by 29.54% reported in 2018Q4 SEC filing. Punch & Associates Investment ...
-
Angiosarcoma observed in 1 in 1,000 patients after radiotherapy for breast cancer - Healio
Posted: March 18th, 2019, 10:30am GMT
Angiosarcoma observed in 1 in 1,000 patients after radiotherapy for breast cancer HealioAbout 1 in 1000 patients with breast cancer who underwent radiotherapy later developed radiotherapy-associated angiosarcoma, a serious complication for ...
-
Critical Comparison: Vaxart (VXRT) versus TRACON Pharmaceuticals (TCON) - Baseball Daily News
Posted: March 18th, 2019, 10:12am GMT
Critical Comparison: Vaxart (VXRT) versus TRACON Pharmaceuticals (TCON) Baseball Daily NewsVaxart (NASDAQ:VXRT) and TRACON Pharmaceuticals (NASDAQ:TCON) are both small-cap medical companies, but which is the superior business? We will ...
-
Kodiak Sciences Inc. (KOD) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side - The Moveefy
Posted: March 18th, 2019, 10:48pm GMT
Kodiak Sciences Inc. (KOD) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side The MoveefyBoth Kodiak Sciences Inc. (NASDAQ:KOD) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are each other's competitor in the Biotechnology industry.
-
Athenex, Inc. (ATNX) Increases to $11.87 on Mar, 17 - The EN Bulletin
Posted: March 17th, 2019, 4:51pm GMT
Athenex, Inc. (ATNX) Increases to $11.87 on Mar, 17 The EN BulletinAthenex, Inc. (NASDAQ:ATNX) increased significantly to $11.87. Barchart.com reported the move on Mar, 17. It has $795.57 million MC. At $12.34 stock target,
-
Comparing of ImmunoCellular Therapeutics Ltd. (IMUC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - Standard Recorder
Posted: March 17th, 2019, 3:28pm GMT
Comparing of ImmunoCellular Therapeutics Ltd. (IMUC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Standard RecorderImmunoCellular Therapeutics Ltd. (OTCMKTS:IMUC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete with each other in the Biotechnology sector ...
-
Athenex, Inc. (ATNX) Reaches $11.87 After 8.00% Up Move; Horizon Kinetics Has Raised By $1.82 Million Its Oaktree Cap Group (OAK) Position - Lives Advice
Posted: March 17th, 2019, 1:52pm GMT
Athenex, Inc. (ATNX) Reaches $11.87 After 8.00% Up Move; Horizon Kinetics Has Raised By $1.82 Million Its Oaktree Cap Group (OAK) Position Lives AdviceThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock increased 4.21% or $0.48 during the last trading session, reaching $11.87.
-
Reviewing Epizyme Inc. (EPZM)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The FinHeadLines
Posted: March 17th, 2019, 10:17am GMT
Reviewing Epizyme Inc. (EPZM)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results The FinHeadLinesEpizyme Inc. (NASDAQ:EPZM) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), are influenced by contrast since they are both players in the ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM)'s results - The Moveefy
Posted: March 17th, 2019, 3:48am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM)'s results The MoveefyBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) are Biotechnology companies, competing one ...
-
Arcus Biosciences Inc. (RCUS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side - The FinExaminer
Posted: March 17th, 2019, 12:05am GMT
Arcus Biosciences Inc. (RCUS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side The FinExaminerArcus Biosciences Inc. (NYSE:RCUS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), both competing one another are Biotechnology companies. We will ...
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and OHR Pharmaceutical Inc. (NASDAQ:OHRP) - The FinExaminer
Posted: March 17th, 2019, 11:51pm GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and OHR Pharmaceutical Inc. (NASDAQ:OHRP) The FinExaminerTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and OHR Pharmaceutical Inc. (NASDAQ:OHRP) compete with each other in the Biotechnology sector. We will ...
-
Corcept Therapeutics Incorporated (CORT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side - Port Courier
Posted: March 17th, 2019, 10:12pm GMT
Corcept Therapeutics Incorporated (CORT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side Port CourierThis is therefore a contrasting of the analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation in Corcept.
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Aytu BioScience Inc. (NASDAQ:AYTU)'s results - The Moveefy
Posted: March 16th, 2019, 8:37pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Aytu BioScience Inc. (NASDAQ:AYTU)'s results The MoveefyThis is a contrast between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Aytu BioScience Inc. (NASDAQ:AYTU) based on their dividends, analyst ...
-
Aptevo Therapeutics Inc. (APVO)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - Lives Advice
Posted: March 16th, 2019, 7:53pm GMT
Aptevo Therapeutics Inc. (APVO)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Lives AdviceThis is a contrast between Aptevo Therapeutics Inc. (NASDAQ:APVO) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) based on their analyst ...
-
ASLAN Pharmaceuticals Limited (ASLN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side - Lives Advice
Posted: March 16th, 2019, 6:24pm GMT
ASLAN Pharmaceuticals Limited (ASLN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side Lives AdviceASLAN Pharmaceuticals Limited (NASDAQ:ASLN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) have been rivals in the Biotechnology for quite some ...
-
Athenex, Inc. (ATNX) Trades at $11.87 After Triangle; Meiji Yasuda Life Insurance Company Increased Medtronic Plc (MDT) Holding - The FinExaminer
Posted: March 16th, 2019, 11:28am GMT
Athenex, Inc. (ATNX) Trades at $11.87 After Triangle; Meiji Yasuda Life Insurance Company Increased Medtronic Plc (MDT) Holding The FinExaminerAthenex, Inc. (ATNX) formed triangle with $10.92 target or 8.00% below today's $11.87 share price. Athenex, Inc. (ATNX) has $795.57 million valuation.
-
Contrasting Vaxart (VXRT) & TRACON Pharmaceuticals (NASDAQ:TCON) - Fairfield Current
Posted: March 16th, 2019, 8:27am GMT
Contrasting Vaxart (VXRT) & TRACON Pharmaceuticals (NASDAQ:TCON) Fairfield CurrentVaxart (NASDAQ:VXRT) and TRACON Pharmaceuticals (NASDAQ:TCON) are both small-cap medical companies, but which is the superior stock? We will ...
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Arvinas Holding Company LLC (NASDAQ:ARVN) - The FinHeadLines
Posted: March 16th, 2019, 4:23am GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Arvinas Holding Company LLC (NASDAQ:ARVN) The FinHeadLinesTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Arvinas Holding Company LLC (NASDAQ:ARVN), are influenced by contrast since they are both players ...
-
TRACON Pharmaceuticals Inc (TCON) Shares Bought by Telemetry Investments L.L.C. - Baseball Daily News
Posted: March 15th, 2019, 1:33pm GMT
TRACON Pharmaceuticals Inc (TCON) Shares Bought by Telemetry Investments L.L.C. Baseball Daily NewsTelemetry Investments L.L.C. increased its holdings in shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 153.5% in the fourth quarter, according to ...
-
Analysts Set Expectations for TRACON Pharmaceuticals Inc’s Q1 2019 Earnings (TCON) - Fairfield Current
Posted: March 15th, 2019, 8:07am GMT
Analysts Set Expectations for TRACON Pharmaceuticals Inc’s Q1 2019 Earnings (TCON) Fairfield CurrentTRACON Pharmaceuticals Inc (NASDAQ:TCON) – Equities researchers at Jefferies Financial Group issued their Q1 2019 earnings estimates for TRACON ...
-
Comparison of Acasti Pharma Inc. (ACST) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - Lives Advice
Posted: March 15th, 2019, 4:47am GMT
Comparison of Acasti Pharma Inc. (ACST) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Lives AdviceAcasti Pharma Inc. (NASDAQ:ACST) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) have been rivals in the Biotechnology for quite some time. Below is a ...
-
TRACON Pharmaceuticals Inc. (TCON) and Kodiak Sciences Inc. (NASDAQ:KOD) Comparing side by side - The FinReviewer
Posted: March 15th, 2019, 10:01pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Kodiak Sciences Inc. (NASDAQ:KOD) Comparing side by side The FinReviewerTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Kodiak Sciences Inc. (NASDAQ:KOD), both competing one another are Biotechnology companies. We will ...
-
Advaxis Inc. (ADXS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side - Standard Recorder
Posted: March 14th, 2019, 3:37pm GMT
Advaxis Inc. (ADXS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side Standard RecorderThis is a contrast between Advaxis Inc. (NASDAQ:ADXS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) based on their analyst recommendations, ...
-
Angiosarcomas Treatment Market With With Top 20 Countries data : Research Analysis including Growth Factors, Types and Application to 2026 - Gator Ledger
Posted: March 14th, 2019, 1:36pm GMT
Angiosarcomas Treatment Market With With Top 20 Countries data : Research Analysis including Growth Factors, Types and Application to 2026 Gator LedgerAngiosarcomas Treatment Market Research report contains a qualified and in-depth examination of industry which provides overview of Product Specification, ...
-
Cidara Therapeutics (CDTX) and TRACON Pharmaceuticals (TCON) Head to Head Comparison - PressOracle
Posted: March 14th, 2019, 10:09am GMT
Cidara Therapeutics (CDTX) and TRACON Pharmaceuticals (TCON) Head to Head Comparison PressOracleTRACON Pharmaceuticals (NASDAQ:TCON) and Cidara Therapeutics (NASDAQ:CDTX) are both small-cap medical companies, but which is the better ...
-
BidaskScore Reports Athene Holding (ATH) Downgrade; Athenex (ATNX) Sellers Decreased By 2.6% Their Shorts - The Yomi Blog
Posted: March 14th, 2019, 9:23am GMT
BidaskScore Reports Athene Holding (ATH) Downgrade; Athenex (ATNX) Sellers Decreased By 2.6% Their Shorts The Yomi BlogAthenex Inc (NASDAQ:ATNX) had a decrease of 2.6% in short interest. ATNX's SI was 5.60 million shares in March as released by FINRA. Its down 2.6% from ...
-
Global Soft Tissue Sarcoma Treatment Market to Exhibit Significant Opportunity Assessment During 2017 – 2025 - Digital Day News
Posted: March 14th, 2019, 5:16am GMT
Global Soft Tissue Sarcoma Treatment Market to Exhibit Significant Opportunity Assessment During 2017 – 2025 Digital Day NewsSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
Reviewing Alector Inc. (ALEC)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - Thе Mоnіtоr
Posted: March 14th, 2019, 3:46am GMT
Reviewing Alector Inc. (ALEC)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results Thе MоnіtоrBoth Alector Inc. (NASDAQ:ALEC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are each other's competitor in the Biotechnology industry. Thus the ...
-
Regulus Therapeutics Inc. (RGLS)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The Moveefy
Posted: March 14th, 2019, 12:15am GMT
Regulus Therapeutics Inc. (RGLS)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The MoveefyRegulus Therapeutics Inc. (NASDAQ:RGLS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), are influenced by contrast since they are both players in the.
-
Athenex (ATNX) Investors: RBC Capital Reaffirms "Buy" Rating, Sees $29/Share; Fresh Del Monte Produce Has 1.87 Sentiment - The Moveefy
Posted: March 13th, 2019, 11:29am GMT
Athenex (ATNX) Investors: RBC Capital Reaffirms "Buy" Rating, Sees $29/Share; Fresh Del Monte Produce Has 1.87 Sentiment The Moveefy*Fresh* Del Monte Produce Inc (FDP) investors sentiment increased to 1.87 in 2018 Q4. It's up 0.99, from 0.88 in 2018Q3. The ratio increased, as 73 institutional ...
-
Critical Comparison: TRACON Pharmaceuticals (NASDAQ:TCON) and Genocea Biosciences (GNCA) - Fairfield Current
Posted: March 13th, 2019, 9:18am GMT
Critical Comparison: TRACON Pharmaceuticals (NASDAQ:TCON) and Genocea Biosciences (GNCA) Fairfield CurrentGenocea Biosciences (NASDAQ:GNCA) and TRACON Pharmaceuticals (NASDAQ:TCON) are both small-cap medical companies, but which is the better ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) - Standard Recorder
Posted: March 13th, 2019, 1:50am GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) Standard RecorderAs Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Aeglea BioTherapeutics Inc. (NASDAQ:AGLE), are affected by compare.
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Entera Bio Ltd. (NASDAQ:ENTX) - The FinReviewer
Posted: March 13th, 2019, 12:33am GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Entera Bio Ltd. (NASDAQ:ENTX) The FinReviewerThis is therefore a contrasting of the institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations in TRACON.
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Corcept Therapeutics Incorporated (NASDAQ:CORT) - D Minute
Posted: March 12th, 2019, 8:29pm GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Corcept Therapeutics Incorporated (NASDAQ:CORT) D MinuteTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Corcept Therapeutics Incorporated (NASDAQ:CORT), both competing one another are Biotechnology ...
-
CymaBay Therapeutics Inc. (CBAY) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side - The Hi New Ulm
Posted: March 12th, 2019, 4:44pm GMT
CymaBay Therapeutics Inc. (CBAY) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side The Hi New UlmCymaBay Therapeutics Inc. (NASDAQ:CBAY) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), both competing one another are Biotechnology companies.
-
Angiosarcomas Treatment Market Size Archives - Business Herald
Posted: March 12th, 2019, 2:23pm GMT
Angiosarcomas Treatment Market Size Archives Business HeraldVarious types of angiosarcoma include Epithelioid Angiosarcoma, Cardiac Angiosarcoma, Hepatic Angiosarcoma, and Cutaneous Angiosarcoma. As per the ...
-
Angiosarcomas Treatment Market Share Archives - Business Herald
Posted: March 12th, 2019, 2:23pm GMT
Angiosarcomas Treatment Market Share Archives Business HeraldAngiosarcomas Treatment Market Analysis, Growth by Top Companies, Trends by Types and Application, Forecast Analysis to 2026. Various types of ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Myovant Sciences Ltd. (NYSE:MYOV)'s results - The FinHeadLines
Posted: March 12th, 2019, 11:49am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Myovant Sciences Ltd. (NYSE:MYOV)'s results The FinHeadLinesTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Myovant Sciences Ltd. (NYSE:MYOV) have been rivals in the Biotechnology for quite some time. Below is ...
-
Athenex, Inc. (ATNX) Trades at $11.91 After Triangle; Omnova Solutions (OMN) Shorts Increased By 11.19% - Lives Advice
Posted: March 12th, 2019, 10:51am GMT
Athenex, Inc. (ATNX) Trades at $11.91 After Triangle; Omnova Solutions (OMN) Shorts Increased By 11.19% Lives AdviceOmnova Solutions Inc (NYSE:OMN) had an increase of 11.19% in short interest. OMN's SI was 322,900 shares in March as released by FINRA. Its up 11.19% ...
-
Animal research saves people and their pets from cancer - The Independent | SUindependent.com
Posted: March 12th, 2019, 9:02am GMT
Animal research saves people and their pets from cancer The Independent | SUindependent.comWe need to do everything we can to fight cancer. As multiple Nobel laureates have proven, animal research is crucial to that effort.
-
Angiosarcomas Treatment Market Growth by 2026: Companies, Opportunities, Challenges, Growth, Countries, Revenue - Plains Gazette
Posted: March 12th, 2019, 6:29am GMT
Angiosarcomas Treatment Market Growth by 2026: Companies, Opportunities, Challenges, Growth, Countries, Revenue Plains GazetteGlobal Angiosarcomas Treatment Market Analysis, Size, Share, Outlook and Forecast to 2018-2026 is a professional and in-depth research report on the world's ...
-
Reviewing Regulus Therapeutics Inc. (RGLS)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The Moveefy
Posted: March 12th, 2019, 12:22am GMT
Reviewing Regulus Therapeutics Inc. (RGLS)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results The MoveefyRegulus Therapeutics Inc. (NASDAQ:RGLS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), both competing one another are Biotechnology companies.
-
Comparing of Genprex Inc. (GNPX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - Standard Recorder
Posted: March 12th, 2019, 12:12am GMT
Comparing of Genprex Inc. (GNPX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Standard RecorderGenprex Inc. (NASDAQ:GNPX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are two firms in the Biotechnology that compete against each other.
-
Athenex, Inc. (ATNX) Q4 2018 Earnings Conference Call Transcript - The Motley Fool
Posted: March 11th, 2019, 6:14pm GMT
Athenex, Inc. (ATNX) Q4 2018 Earnings Conference Call Transcript The Motley FoolATNX earnings call for the period ending December 31, 2018.
-
TRACON Pharmaceuticals (TCON) Lowered to “Hold” at Zacks Investment Research - XNewsPress
Posted: March 11th, 2019, 4:11pm GMT
TRACON Pharmaceuticals (TCON) Lowered to “Hold” at Zacks Investment Research XNewsPressZacks Investment Research downgraded shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a strong-buy rating to a hold rating in a research report ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Kindred Biosciences Inc. (NASDAQ:KIN) - D Minute
Posted: March 11th, 2019, 2:28pm GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Kindred Biosciences Inc. (NASDAQ:KIN) D MinuteBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Kindred Biosciences Inc. (NASDAQ:KIN) compete on a level playing field in the Biotechnology ...
-
Athenex Q4 top line up 43% - Seeking Alpha
Posted: March 11th, 2019, 9:19am GMT
Athenex Q4 top line up 43% Seeking AlphaAthenex (ATNX) Q4 results: Revenues: $21.3M (+43.0%). Net Loss: ($27.1M) (+4.2%); Loss Per Share: ($0.41) (+16.3%); Quick Assets: $107.4M (+110.6%); CF ...
-
Athenex, Inc. Announces Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update - GlobeNewswire
Posted: March 11th, 2019, 9:00am GMT
Athenex, Inc. Announces Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update GlobeNewswireOraxol Phase III clinical trial in metastatic breast cancer fully enrolled. Positive Phase III topline results of KX2-391 in actinic keratosis featured in late breaker ...
-
TRACON Pharmaceuticals (TCON) Cut to Hold at Zacks Investment Research - Fairfield Current
Posted: March 11th, 2019, 8:30am GMT
TRACON Pharmaceuticals (TCON) Cut to Hold at Zacks Investment Research Fairfield CurrentZacks Investment Research downgraded shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a strong-buy rating to a hold rating in a research note ...
-
ASLAN Pharmaceuticals Limited (ASLN)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) | Hi New Ulm - The Hi New Ulm
Posted: March 9th, 2019, 9:01pm GMT
ASLAN Pharmaceuticals Limited (ASLN)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) | Hi New Ulm The Hi New UlmASLAN Pharmaceuticals Limited (NASDAQ:ASLN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), are influenced by contrast since they are both players ...
-
ASLAN Pharmaceuticals Limited (ASLN)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - Standard Recorder
Posted: March 9th, 2019, 9:55am GMT
ASLAN Pharmaceuticals Limited (ASLN)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Standard RecorderBoth ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are Biotechnology companies, competing one ...
-
Vaxart (VXRT) & TRACON Pharmaceuticals (TCON) Head-To-Head Analysis - Fairfield Current
Posted: March 9th, 2019, 9:21am GMT
Vaxart (VXRT) & TRACON Pharmaceuticals (TCON) Head-To-Head Analysis Fairfield CurrentVaxart (NASDAQ:VXRT) and TRACON Pharmaceuticals (NASDAQ:TCON) are both small-cap medical companies, but which is the superior investment? We will ...
-
Angiosarcomas Treatment Market 2018 Opportunities, Competition from Opponents, Dynamics, Demand, Challenge and Risk and Forecast to 2026 - Oak Tribune
Posted: March 9th, 2019, 6:29am GMT
Angiosarcomas Treatment Market 2018 Opportunities, Competition from Opponents, Dynamics, Demand, Challenge and Risk and Forecast to 2026 Oak TribuneAngiosarcomas Treatment Market Research Study provides detailed information about the key factors influencing the growth of the industry which include ...
-
Reviewing CEL-SCI Corporation (CVM)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - Port Courier
Posted: March 9th, 2019, 5:59am GMT
Reviewing CEL-SCI Corporation (CVM)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results Port CourierCEL-SCI Corporation (NYSEAMERICAN:CVM) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are two firms in the Biotechnology that compete against ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Albireo Pharma Inc. (NASDAQ:ALBO) - Standard Recorder
Posted: March 9th, 2019, 3:52am GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Albireo Pharma Inc. (NASDAQ:ALBO) Standard RecorderAs Biotechnology companies, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Albireo Pharma Inc. (NASDAQ:ALBO) are our subject to contrast. And more ...
-
Reviewing Rhythm Pharmaceuticals Inc. (RYTM)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The FinReviewer
Posted: March 8th, 2019, 7:06pm GMT
Reviewing Rhythm Pharmaceuticals Inc. (RYTM)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results The FinReviewerBoth Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are Biotechnology companies, competing one ...
-
Athenex, Inc. (ATNX) Trades at $11.86 After Triangle; Teucrium Corn Fund Etv (NYSEARCA:CORN) Sellers Increased By 65.22% Their Shorts - Standard Recorder
Posted: March 8th, 2019, 12:56pm GMT
Athenex, Inc. (ATNX) Trades at $11.86 After Triangle; Teucrium Corn Fund Etv (NYSEARCA:CORN) Sellers Increased By 65.22% Their Shorts Standard RecorderAthenex, Inc. (ATNX) formed triangle with $10.91 target or 8.00% below today's $11.86 share price. Athenex, Inc. (ATNX) has $793.50M valuation. The stock ...
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) - The FinReviewer
Posted: March 8th, 2019, 12:42pm GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) The FinReviewerTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF), both competing one another are Biotechnology ...
-
Athenex to Present Preclinical Data of Oraxol in the Treatment of Angiosarcoma at the American Association for Cancer Research Annual Meeting 2019 - GlobeNewswire
Posted: March 8th, 2019, 10:00am GMT
Athenex to Present Preclinical Data of Oraxol in the Treatment of Angiosarcoma at the American Association for Cancer Research Annual Meeting 2019 GlobeNewswireBUFFALO, N.Y., March 08, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, ...
-
TRACON Pharmaceuticals Inc (TCON) Forecasted to Earn Q1 2019 Earnings of ($0.27) Per Share - Fairfield Current
Posted: March 8th, 2019, 9:05am GMT
TRACON Pharmaceuticals Inc (TCON) Forecasted to Earn Q1 2019 Earnings of ($0.27) Per Share Fairfield CurrentTRACON Pharmaceuticals Inc (NASDAQ:TCON) – Jefferies Financial Group issued their Q1 2019 earnings per share estimates for shares of TRACON ...
-
The Skin's Role in Immunity - The Dermatologist
Posted: March 7th, 2019, 5:25pm GMT
The Skin's Role in Immunity The DermatologistIn almost all fields of health research, immunity is a hot topic. Dermatology is no exception. The skin has long been recognized as a major component of the ...
-
Investors Real Estate Trust (IRET) to pay $0.70 on Apr 1, 2019; Athenex (ATNX) Shorts Decreased By 2.6% - The FinExaminer
Posted: March 7th, 2019, 3:09pm GMT
Investors Real Estate Trust (IRET) to pay $0.70 on Apr 1, 2019; Athenex (ATNX) Shorts Decreased By 2.6% The FinExaminerInvestors Real Estate Trust (NYSE:IRET) is expected to pay $0.70 on Apr 1, 2019. (NYSE:IRET) shareholders before Mar 14, 2019 will receive the $0.70 ...
-
TRACON Pharmaceuticals (TCON) Upgraded by Zacks Investment Research to “Strong-Buy” - Fairfield Current
Posted: March 7th, 2019, 2:24pm GMT
TRACON Pharmaceuticals (TCON) Upgraded by Zacks Investment Research to “Strong-Buy” Fairfield CurrentZacks Investment Research upgraded shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a hold rating to a strong-buy rating in a research note ...